CATX:NYSEMKT, Perspective Therapeutics, Inc.

Why CATX stock rose on November 13

Perspective Therapeutics, Inc. rose 11.9% on Friday, November 13, 2026, on 3,183,400 shares. No headline about CATX came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

CATX stock overview

Perspective Therapeutics, Inc. (CATX:NYSEMKT) closed at $0.924 on November 16, 2026, down 2.05% on the day. The stock trades 85.0% below its 52-week high of $6.16 and 18.4% above its 52-week low of $0.780. Over the past year, it lost 59.5%. Perspective Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$0.924
Day change
-2.05%
Volume
2,300,146
Average volume
2,620,220
Market cap
111M+
52-week range
$0.780 – $6.16
50-day average
$2.11
200-day average
$3.45

Price action over the past year

In 252 trading sessions since November 14, 2025, CATX closed higher on 115 days (46%). Its best day was January 29, 2026 (+66.41%) and its worst was October 23, 2026 (-28.76%). The stock moved 10% or more in a single session 13 times.

Recent signals

CATX news

About Perspective Therapeutics, Inc.

Isoray Inc offers is a medical technology company. The company designs and develops personalized brachytherapy products that provide a more cost-effective cancer treatment. It is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. Isoray derives most of its revenue from the United States of America.

Similar stocks

Find more stocks like CATX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.